Skip to main content
An official website of the United States government

Gastrointestinal and Other Cancers

Conducts and supports prevention and early detection research for colorectal, esophageal, liver, pancreatic, and hematolymphoid cancers. Supports development of new approaches for clinical prevention studies, including cancer immunoprevention.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Della'Zanna, Gary, D.O., M.Sc.
gary.dellazanna@nih.gov
240-276-7042
5E234 Program Officer | Gastrointestinal and Other Cancers
Garvey, Rodshae
garveyrj@nih.gov
240-276-5764
5E220 Program Support Assistant | Gastrointestinal and Other Cancers
Program Support Assistant | Lung and Upper Aerodigestive Cancer
Rodriguez, Luz Maria, M.D., FACS
luz.rodriguez@nih.gov
240-276-7039
5E228 Program Officer | Gastrointestinal and Other Cancers
Umar, Asad, D.V.M., Ph.D.
asad_umar@nih.gov
240-276-7038
5E226 Chief | Gastrointestinal and Other Cancers

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Zhou, Xianghong Jasmine

University Of California Los Angeles
United States

The UCLA Center in Early Detection of Liver Cancer 5U01CA230705-08 Sidney Fu, M.D.
Zhu, Yazhen

University Of California Los Angeles
United States

Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles 5R01CA277530-03 Matthew Young, Ph.D.
Zhu, Yong

Univ Of Arkansas For Med Scis
United States

Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection 1R21CA277412-01A1 Christos Patriotis, Ph.D., M.Sc.
Zhu, Yazhen

University Of California Los Angeles
United States

Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma 5R01CA255727-05 Matthew Young, Ph.D.
Zi, Xiaolin

University Of California-Irvine
United States

Nautral products for targeting Skp2 in cancer interception 5UG3CA290368-02 Altaf Mohammed, Ph.D.